Patents Assigned to Dr. Thomas RUDEL
  • PROHIBITIN AS TARGET FOR CANCER THERAPY
    Publication number: 20120121575
    Abstract: The present invention relates to pharmaceutical compositions comprising inhibitors of Prohibitin (PHB) for the prevention or/and treatment of hyperproliferative disorders.
    Type: Application
    Filed: October 18, 2011
    Publication date: May 17, 2012
    Applicant: Dr. Thomas RUDEL
    Inventors: Krishnaraj RAJALINGAM, Thomas RUDEL